Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis

Annals of Hepatology · Published 2026-05-01 · DOI 10.1016/j.aohep.2026.102221

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.aohep.2026.102221

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress? · Alimentary Pharmacology and Therapeutics · 2026 · Cites or is cited by this article
• Metabolic dysfunction–associated steatotic liver disease: No alcohol · Annals of Hepatology · 2026 · Same journal
• The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease · Annals of Hepatology · 2026 · Same journal
• The global academic hepatology capacity index (IGCAH): a multi-source assessment reveals profound inequities across Latin America · Annals of Hepatology · 2026 · Same journal
• The AMAGE guidelines: Metabolic dysfunction-associated fatty liver disease through a regional lens · Annals of Hepatology · 2026 · Same journal
• Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease · Annals of Hepatology · 2026 · Same journal
• Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study · Annals of Hepatology · 2025 · Same journal
• Pragmatism should not eclipse validation in expanded HBV management for Latin America: response · Annals of Hepatology · 2026 · Same journal
• Mesencephalic astrocyte-derived neurotrophic factor (MANF): a context-dependent therapeutic regulator and potential biomarker in liver diseases · Annals of Hepatology · 2026 · Same journal
• The role of inpatient palliative care consultation in end-stage liver disease: Too little, too late? · Annals of Hepatology · 2026 · Same journal